Gwen A. Fyfe is Director at ARRAY BIOPHARMA INC (ARRY). They have made 1 open-market trade across 1 company since 2017, most recently 2019-07-30.
CIK 0001506217
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $7K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CASC | BUY | 2017-03-28 | 2017-03-30 | $4.12 | $7K | -6.0% | +2.6% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.